Influence of estrogen, antiestrogen and UV-light on the balance between proliferation and apoptosis in MCF-7 breast adenocarcinoma cells culture

Neoplasma

Volumn 47, Issue 1, 2000, Pages 15-24

  Swiatecka J ^a   DziecioL J ^b   Anchim, T ^b   Dabrowska M ^b   Pietruczuk, M ^b   Wolczynski S ^b  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b NONE

Author keywords

Apoptosis; Breast cancer; Estradiol; MCF 7 cells; Proliferation; Tamoxifen; Ultraviolet

Indexed keywords

CYCLINE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; GENE PRODUCT; PROTEIN BCL 2; PROTEIN P53; TAMOXIFEN; THYMIDINE;

APOPTOSIS; ARTICLE; BREAST ADENOCARCINOMA; CANCER CELL CULTURE; CARCINOMA CELL; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PROTEIN EXPRESSION; ULTRAVIOLET RADIATION;

EID: 0343183950     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. ALLEN, R.T., CLUCK. M.W., AGRAWAL, D.K.: Mechanism controlling cellular suicide: Role of Bcl-2 and caspases. Cell Mol. Life Sci., 54, 1998, 427-445.
2. ARAGNE, Y. KULMS, D., METZE, D., WILKES, G., POPPELMAN, B., LUGER, T.A., SCHWARZ, T.: Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/Apo-1) independently of its ligand CD95L. J. Cell Biol., 12, 1998, 171-182.
3. BARDON, S., VIGNON, K., DEROCO, D., ROCHEFORT, H.: The antiproliferative effect of tamoxifen in breast cancer cells: Mediation by estrogen receptor. Mol. Cell Endocrinol., 35, 1984, 89-96.
4. CORADINI, D., BIFFI, A., CAPPELLETTI, V., DI FRONZO, G.: Activity of tamoxifen and new antiestrogens on estrogen receptor positive and negative breast cancer cells. Anticancer Res., 14, 1994, 3A, 1059-1064.
5. CHEN, H., TRITTON, T.R., KENNY, N., ABSHER, M., CHIU, J.F: Tamoxifen induces TGF-beta 1 activity and apoptosis of human MCF-7 breast cancer cells in vitro. J. Cell Biochem., 61, 1996, 9-17.
6. GUPTA, V., NARAYANA, K., TKALCEVIC, G.T., SINGH, S.V.: Potentiation of tamoxifen activity by verapamil in a human breast cancer cell line. Biochem. Pharmacol., 47, 1994, 1701-1704.
7. HALDAR, S., NEGRINI, M., MONNE, M., SABBIONI, S., CROCE, C.M.: Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res., 54, 1994, 2095-2097.
8. JORDAN, V.C., MURPHY, C.S.: Endocrine pharmacology of antiestrogens as antitumor agents. Endocr. Rev., 11, 1990, 578-610.
9. KANDOUZ, M., SIROMACHKOVA, M., JACOB, D., CHRETIEN MARQUET, B., THERWATH, A., COMPEL, A.: Antagonism between estradiol and progestin on Bcl-2 expression in breast-cancer cells. Int. J. Cancer, 68, 1996, 120-125.
10. KASTAN, M.B., ONYEKWERE, O., SIDRANSKY, D., VOGELSTEIN, B., CRAIG, R.W.: Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51, 1991, 6304-6311.
11. KUIPER, G.G., CARLSSON, B., GRANDIER, K., ENMARK, E., HAGGBLAD, J., NILSSON, S., GUSTAFSSON, J.A.: Comparison of the ligand binding specifity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology, 138, 1997, 863-870.
12. LEE, Y.J., GALOFORO, S.S., BERNS, C.M., ERDOS, G., GUPTA, A.K., WAYS, D.K., CORRY, P.M.: Effect of ionising radiation on AP-1 binding activity and basic fibroblast growth factor gene expression in drug-sensitive human breast carcinoma MCF-7 and multidrug-resistant MCF-7/ADR cells. J. Biol. Chem., 270, 1995, 28 790-28 796.
13. ORREN, D.K., PETERSEN, L.N., BOHR, VA.: Persistent DNA damage inhibits S-phase and G2 progression, and results in apoptosis. Mol. Biol. Cell, 7, 1997, 1129-1142.
14. PEACH, K., WEBB, P., KUIPER, G.G., NILSSON, S., GUSTAFSSON, J., KUSHNER, P.J., SCANLAN, T.S.: Differential ligand activation of estrogen receptors ERalpha and ERbeta at API sites. Science, 277, 1997, 1508-1510.
15. PERRY, R.R., KANG, Y., GREAVES, B.R.: Relationship between tamoxifen-induced transforming growth factor beta 1 expression, cytostasis and apoptosis in human breast cancer cells. Br. J. Cancer, 72, 1995, 1441-1446.
16. ROCHEFORT, H., BARDON, S., CHALBOS, D., VIGNON, F.: Steroidal and nonsteroidal antiestrogens in breast cancer celts culture. J. Steroid Biochem., 20, 1984, 105-110.
17. SAKAKURA, C., SWEENEY, E.A., SHIRAHAMA, T., IGARASHI, Y., HAKOMORI, S., NAKATANI, H., TSUJIMOTO, H., IMANISHI, T., OHGAKI, M., OHYAMA, T., YAMAZAKI, J., HAGIWARA, A., YAMAGUCHI, T., SAWAI, K., TAKAHASHI, K.: Overexpression of bax sensitizes human breast cancer MCF-7 cells to radiation-induced apoptosis. Int. J. Cancer, 67, 1996, 101-105.
18. SCHOENLEIN, P.V., LEWIS, J., BARRETT, J.T., WILSON, J.D., Li-ANG, Y., EL ETREBY, M.F.: Analysis of tamoxifen-induced chromosomal DNA fragmentation with pulsed field gel electrophoresis. Meeting abstract. Proc. Annu. Meet. Am. Assoc. Cancer Res., 38, 1997, A762.
19. TAO, X.J., SAYEGH, R.A., TILLY, J.L., ISAACSON, K.B.: Elevated expression of the proapoptotic Bcl-2 family member, BAK, in the human endometrium coincident with apoptosis during the secretory phase of the cycle. Fertil. Steril., 70, 1998, 338-343.
20. VAN DER BURG, B., DE GROOT, R.P., ISBRÜCKER, L., KRUUER, W., DE LAAT, S.W.: Direct stimulation by estrogen of growth factor signal transduction pathways in human breast cancer cells. J. Steroid Biochem. Mol. Biol., 43, 1992, 111-115.
21. VON RANGO, U., CLASSEN-LINKE, I., KRUSCHE, C.A., BEIER, H.M.: The receptive endometrium is characterized by apoptosis in the glands. Hum. Reprod., 113, 1998, 3177-3189.